These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19439734)

  • 1. Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells.
    Becker C; Taube C; Bopp T; Becker C; Michel K; Kubach J; Reuter S; Dehzad N; Neurath MF; Reifenberg K; Schneider FJ; Schmitt E; Jonuleit H
    Blood; 2009 Aug; 114(6):1263-9. PubMed ID: 19439734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression.
    Ji J; Cloyd MW
    Int Immunol; 2009 Mar; 21(3):283-94. PubMed ID: 19208751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
    Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
    Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very Low Numbers of CD4
    Copsel S; Wolf D; Kale B; Barreras H; Lightbourn CO; Bader CS; Alperstein W; Altman NH; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1788-1794. PubMed ID: 29751114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
    Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
    J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment.
    Pierini A; Strober W; Moffett C; Baker J; Nishikii H; Alvarez M; Pan Y; Schneidawind D; Meyer E; Negrin RS
    Blood; 2016 Aug; 128(6):866-71. PubMed ID: 27365424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
    Pozo D; Anderson P; Gonzalez-Rey E
    J Immunol; 2009 Oct; 183(7):4346-59. PubMed ID: 19734220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-mediated regulatory T-cell activation inhibits the development of disease in a humanized mouse model of allergic airway disease.
    Martin H; Reuter S; Dehzad N; Heinz A; Bellinghausen I; Saloga J; Haasler I; Korn S; Jonuleit H; Buhl R; Becker C; Taube C
    J Allergy Clin Immunol; 2012 Feb; 129(2):521-8, 528.e1-7. PubMed ID: 22078574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
    Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
    Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo.
    Stevceva L; Yoon V; Carville A; Pacheco B; Santosuosso M; Korioth-Schmitz B; Mansfield K; Poznansky MC
    J Immunol; 2008 Oct; 181(8):5510-21. PubMed ID: 18832708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
    Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
    Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo.
    Pankratz S; Bittner S; Herrmann AM; Schuhmann MK; Ruck T; Meuth SG; Wiendl H
    FASEB J; 2014 Aug; 28(8):3435-45. PubMed ID: 24744146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
    Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
    Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8.
    Stockis J; Liénart S; Colau D; Collignon A; Nishimura SL; Sheppard D; Coulie PG; Lucas S
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10161-E10168. PubMed ID: 29109269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-covalent complexes of HIV gp120 with CD4 and/or mAbs enhance activation of gp120-specific T clones and provide intermolecular help for anti-CD4 antibody production.
    Manca F; Seravalli E; Valle MT; Fenoglio D; Kunkl A; Li Pira G; Zolla-Pazner S; Celada F
    Int Immunol; 1993 Sep; 5(9):1109-17. PubMed ID: 7902128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway.
    Zhang B; Yeo RWY; Lai RC; Sim EWK; Chin KC; Lim SK
    Cytotherapy; 2018 May; 20(5):687-696. PubMed ID: 29622483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T Cells Contribute to HIV-1 Reservoir Persistence in CD4+ T Cells Through Cyclic Adenosine Monophosphate-Dependent Mechanisms in Humanized Mice In Vivo.
    Li G; Nunoya JI; Cheng L; Reszka-Blanco N; Tsao LC; Jeffrey J; Su L
    J Infect Dis; 2017 Dec; 216(12):1579-1591. PubMed ID: 29045701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
    Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB
    Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity.
    Tran GT; Hodgkinson SJ; Carter NM; Verma ND; Plain KM; Boyd R; Robinson CM; Nomura M; Killingsworth M; Hall BM
    Blood; 2012 May; 119(19):4441-50. PubMed ID: 22310911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.